Breast cancer early detection methods for low and middle income countries, a review of the evidence

Breast

Volumn 21, Issue 4, 2012, Pages 428-434

  Corbex, Marilys ^a   Burton, Robert ^b   Sancho Garnier, Hélène ^c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MONASH UNIVERSITY   (Australia)

^c Epidaure pôle prévention CRLC Montpellier   (France)

Author keywords

Breast self exam; Clinical breast exam; Clinical downstaging; Mammography

Indexed keywords

BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL BREAST EXAMINATION; CLINICAL EFFECTIVENESS; DEVELOPING COUNTRY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; HEALTH CARE COST; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 84861394337     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.01.002     Document Type: Review

References (65)

1. Althuis M.D., Dozier J.M., Anderson W.F., Devesa S.S., Brinton L.A. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005 Apr, 34(2):405-412.
2. Parkin D.M., Fernández L.M. Use of statistics to assess the global burden of breast cancer. Breast J 2006 Jan-Feb, 12(Suppl. 1):S70-S80. [Review].
3. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] 2010, GLOBOCAN 2008, International Agency for Research on Cancer, Lyon, France, Available from:. http://globocan.iarc.fr.
4. WHA 58.22-World Health Assembly resolution and decision - cancer prevention and controls May 2005, Full txt available at:. http://apps.who.int/gb/ebwha/pdf_files/WHA58/WHA58_22-en.pdf.
5. Kingsbury K. The changing face of breast cancer. Cover - why breast cancer is spreading around the world?. Time Magazine Oct 4, 2007.
6. Lemmert U.S. - Middle East partnership for breast cancer awareness and research marks one year of touching lives in the Arab world June 2007, Full text available at:. http://www.bcpartnership.org/news-and-resources/docs/oneyear.pdf.
7. Yip C.H., Smith R.A., Anderson B.O., Miller A.B., Thomas D.B., Ang E.S., et al. Guideline implementation for breast healthcare in low- and middle-income countries. Cancer 2008, 113(8):2244. on behalf of the Breast Health Global Initiative Early Detection panel.
8. Bouchlaka A., Ben Abdallah M., Ben Aissa R., Zaanouni E., Kribi L., Smida S., et al. Results and evaluation of 3 years of a large scale mammography program in the Ariana area of Tunisia. Tunis Med 2009 Jul, 87(7):438-444.
9. Harford J.B. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol 2011 Mar, 12(3):306-312.
10. European Commission European Guidelines for quality assurance in breast cancer screening and diagnosis 2006, Office for Official Publications of the European Communities, L 2985 Luxembourg. 4th ed. N. Perry, M. Broeders, C. de Wolf, S. Tömberg, R. Holland, L. von Karsa (Eds.).
11. Kerlikowske K., Grady D., Barclay J., Frankel S.D., Ominsky S.H., Sickles E.A., et al. Variability and accuracy in mammographic interpretation using the American College of Radiology breast imaging reporting and data system. J Natl Cancer Inst 1998, 90(23):1801-1809.
12. Barlow W.E., Chi C., Carney P.A., Taplin S.H., D'Orsi C., Cutter G., et al. Accuracy of screening mammography interpretation by characteristics of radiologists. J Natl Cancer Inst 2004, 96(24):1840-1850.
13. IARC handbooks of cancer prevention. Breast cancer screening 2002, vol. 7. IARC press, Lyon.
14. Anttinen I., Pamilo M., Soiva M., Roiha M. Double reading of mammography screening films-one radiologist or two?. Clin Radiol 1993 Dec, 48(6):414-421.
15. Shapiro S., Strax P., Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA 1966, 195:111-118.
16. Nyström L., Andersson I., Bjurstam N., Frisell J., Nordenskjöld B., Rutqvist L.E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002 Mar 16, 359(9310):909-919. Review. Erratum in: Lancet 2002 Aug 31;360(9334):724.
17. Kerlikowske K., Grady D., Barclay J., Sickles E.A., Ernster V. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA 1996, 276(1):39-43.
18. Demissie K., Mills O.F., Rhoads G.G. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 1998 Feb, 51(2):81-91.
19. Gotzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006, (4). Art. No.: CD001877. 10.1002/14651858.CD001877.pub2.
20. USPSTF Screening for breast cancer: U.S. Preventive services task force recommendation Statement. Ann Intern Med 2009, 151:716-726. Freely available at:. http://www.ahrq.gov/clinic/uspstf09/breastcancer/brcanrs.htm.
21. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L. U.S. Preventive services task force. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med 2009 Nov 17, 151(10):727-737. W237-42. Review.
22. Quanstrum K.H., Hayward R.A. Lessons from the mammography wars. N Engl J Med 2010 Sep 9, 363(11):1076-1079.
23. Zackrisson S., Andersson I., Janzon L., Manjer J., Garne J.P. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006, 332(7543):689-692.
24. Welch H.G. Overdiagnosis and mammography screening: the question is no longer whether, but how often it occurs. BMJ 2009, 339:b1425.
25. Welch H.G., Black W.C. Overdiagnosis in cancer. J Natl Cancer Inst 2010 Apr 22.
26. Jørgensen K.J., Gøtzsche P.C. Overdiagnosis in publicly organized mammography screening programmes: systematic review of incidence trends. BMJ 2009, 339:b2587.
27. Morrell S., Barratt A., Irwig L., Howard L., Biesheuvel C., Armstrong B. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2009, 21:275-282.
28. McPherson K. Screening for breast cancer-balancing the debate. BMJ 2010, 340:c3106.
29. Partridge A.H., Winer E.P. On mammography - more agreement than disagreement November 25, 2009, 10.1056/NEJMp0911288. http://www.nejm.org.
30. Muscat J.E., Huncharek M.S. Breast self-examination and extent of disease: a population-based study. Cancer Detect Prev 1991, 15:155-159.
31. Newcomb P.A., Weiss N.S., Storer B.E., Scholes D., Young B.E., Voigt L.F. Breast self-examination in relation to the occurrence of advanced breast cancer. J Natl Cancer Inst 1991, 83(4):260-265.
32. Gastrin G., Miller A.B., To T., Aronson K.J., Wall C., Hakama M., et al. Incidence and mortality from breast cancer in the Mama program for breast screening in Finland, 1973-1986. Cancer 1994, 73:2168-2174.
33. Harvey B.J., Miller A.B., Baines C.J., Corey P.N. Effect of breast self-examination techniques on the risk of death from breast cancer. CMAJ 1997, 157(9):1205-1212.
34. Holmberg L., Ekbom A., Calle E., Mokdad A., Byers T. Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450,000 women. Breast Cancer Res Treat 1997, 43(2):137-140.
35. Semiglazov V.F., Manikhas A.G., Moiseenko V.M., Protsenko S.A., Kharikova R.S., Seleznev I.K., et al. Results of a prospective randomized investigation [Russia (St. Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer. Vopr Onkol 2003, 49(4):434-441.
36. Thomas D.B., Gao D.L., Ray R.M., Wang W.W., Allison C.J., Chen F.L., et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002 Oct 2, 94(19):1445-1457.
37. Kosters J.P., Gotszsche P.C. Regular self-examination or clinical examination for early detection of breast cancer (Review) 2008, John Wiley & Sons Ltd, (for The Cochrane Collaboration).
38. McCready T., Littlewood D., Jenkinson J. Breast self-examination and breast awareness: a literature review. J Clin Nurs 2005 May, 14(5):570-578. [Review].
39. Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?. CMAJ 2001, 164(13):1837-1846. Canadian Task Force on Preventive Health Care.
40. WHO Guide for effective programmes; cancer control: knowledge into action; module 3: early detection 2007, (free full text). http://www.who.int/cancer/modules/en/index.html.
41. Baines C.J., Miller A.B., Bassett A.A. Physical examination. Its role as a single screening modality in the Canadian national breast screening study. Cancer 1989 May 1, 63(9):1816-1822.
42. Miller A.B., To T., Baines C.J., Wall C. Canadian national breast screening study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000 Sep 20, 92(18):1490-1499.
43. Miller A.B., To T., Baines C.J., Wall C. The Canadian national breast screening study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002 Sep 3, 137(5 Part 1):305-312.
44. Periodic screening for breast cancer 1988, Johns Hopkins University Press, Baltimore. S. Shapiro, W. Venet, P. Strax (Eds.).
45. Miller A.B. Early detection of breast cancer in the emerging world. Zentralbl Gynakol 2006 Aug, 128(4):191-195.
46. Pisani P., Parkin D.M., Ngelangel C., Esteban D., Gibson L., Munson M., et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006 Jan 1, 118(1):149-154.
47. Dinshaw K.A., Shastri S.S., Singh S., Aranke S., Mishra G., Pilankar R., et al. Screening for cervix and breast cancer in Mumbai slums. INCTR Newsl 2003, 4(1). http://www.inctr.org/fileadmin/user_upload/inctr-admin/Network%2520Magazine/Vol%25204%2520%2520No%25201%2520Summer%25202003%2520LLR.pdf.
48. Dinshaw K.A., Shastri S.S., Patil S.S. Cancer control program in India: challenges for the new millenium. Health Adm 2005, XVII(1):10-15. http://medind.nic.in/haa/t05/i1/haat05i1p10.pdf.
49. Mittra I., Mishra G.A., Singh S., Aranke S., Notani P., Badwe R., et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010 Feb 15, 126(4):976-984.
50. Miller A.B. Practical applications for clinical breast examination (CBE) and breast self-examination (BSE) in screening and early detection of breast cancer. Breast Care 2008.
51. Duffy S.W., Tabar L., Vitak B., Warwick J. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?. Breast J 2006 Jan-Feb, 12(Suppl. 1):S91-S95.
52. Okonkwo Q.L., Draisma G., der Kinderen A., Brown M.L., de Koning H.J. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008 Sep 17, 100(18):1290-1300.
53. Bordoni A., Probst-Hensch N.M., Mazzucchelli L., Spitale A. Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study. Br J Cancer 2009 Dec 1, 101(11):1925-1931.
54. De Gelder R., Bulliard J.L., de Wolf C., Fracheboud J., Draisma G., Schopper D., et al. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer 2009 Jan, 45(1):127-138.
55. Hofvind S., Yankaskas B.C., Bulliard J.L., Klabunde C.N., Fracheboud J. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen 2009, 16(3):131-139.
56. Palència L., Espelt A., Rodríguez-Sanz M., Puigpinós R., Pons-Vigués M., Pasarín M.I., et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol 2010 Feb 22.
57. Groot M.T., Baltussen R., Uyl-de Groot C.A., Anderson B.O., Hortobágyi G.N. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, Asia. Breast J 2006 Jan-Feb, 12(Suppl. 1):S81-S90.
58. Stout N.K., Rosenberg M.A., Trentham-Dietz A., Smith M.A., Robinson S.M., Fryback D.G. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006 Jun 7, 98(11):774-782.
59. Tosteson A.N., Stout N.K., Fryback D.G., Acharyya S., Herman B.A., Hannah L.G., et al. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 2008 Jan 1, 148(1):1-10. DMIST Investigators.
60. Lidbrink E., Elfving J., Frisell J., Jonsson E. Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 1996 Feb 3, 312(7026):273-276.
61. Elmore J.G., Barton M.B., Moceri V.M., Polk S., Arena P.J., Fletcher S.W. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998 Apr 16, 338(16):1089-1096.
62. Mittra I. Screening for breast cancer: is it globally applicable?. Nat Clin Pract Oncol 2008 Feb, 5(2):60-61.
63. Luthar UK. Clinical downstaging of cancer of the uterine cervix - an interim strategy for developing countries. In: Proceedings of the UICC congress; 1994.
64. Devi B., Tang Ts, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007 Jul, 18(7):1172-1176.
65. WHO-EMRO regional strategy for cancer control 2008.